Innovation Pharmaceuticals Inc (IPIX)

[wsbc]

Leo's a scammer and a Con.
There's no WAY he's getting legitimate funding with actual oversight involved. Never happened, and likely never will.
The science here has minimal depth verification.
Miniscule trial sizes, statistically insignificant results almost across the board.

IF DeGrado could talk his way into an NIH grant or something, that's likely the only possible way this goes anywhere... But don't kid yourself. Nobody is taking Ehrlich seriously.

BP's had access to the Data Room here, and they want to see larger trial sizes. Leo refuses to run them, so here we sit.

This fund is great for the recipients with legitimate management teams who will actually be able to capitalize on the assistance.

*LE, can U secure $$$??? Probably not.
*Can U drain out SHs $$$??? Absolutely!
*At least can U learn few things..how these guys were able to secure$$$? I'm too old for that and I'm happy with my nest egg (SHs $$).. hahaha


Pharma industry-backed fund invests in two biotech companies to treat 'superbugs...

MRSA (Methicillin-resistant Staphylococcus aureus) bacteria strain is seen in a petri dish containing agar jelly for bacterial culture in a microbiological laboratory in Berlin March 1, 2008. MRSA is a drug-resistant "superbug", which can cause deadly infections. REUTERS/Fabrizio Bensch

April 4 (Reuters) - A $1 billion fund backed by over 20 drugmakers made its first set of investments on Monday in two biotechnology startups, nearly two years after it was launched to help struggling antibiotic makers tackle the threat of antibiotic-resistant bacteria.

The AMR Action fund invested $20 million in Adaptive Phage Therapeutics as part of an ongoing series B round and spent an undisclosed amount in a series C round for Venatorx Pharmaceuticals. The fund plans to invest over $100 million by the end of the year.